Annabelle Santos Volgman to Biomarkers
This is a "connection" page, showing publications Annabelle Santos Volgman has written about Biomarkers.
Connection Strength
0.501
-
The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease. J Alzheimers Dis. 2024; 100(4):1407-1416.
Score: 0.179
-
Sex-Based Considerations in the Evaluation of Chest Pain and Management of Obstructive Coronary Artery Disease. Curr Atheroscler Rep. 2020 06 23; 22(8):39.
Score: 0.140
-
Lipoprotein(a) and Increased Cardiovascular Risk in Women. Clin Cardiol. 2016 Feb; 39(2):96-102.
Score: 0.104
-
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 2022 09 20; 11(18):e025198.
Score: 0.041
-
The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
Score: 0.038